The updated ICH E6 (R3) Good Clinical Practice guidelines are here - discover what's changed and how clinical trials will need to adapt. This in-depth post unravels the key impacts of E6 (R3).

Offered by the Clinical and Translational Science Institute, this micro-credential will prepare learners to be ethical researchers throughout their careers. Participants will investigate how to ...

Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be ...

Anuka Boldbaatar discusses resistance to change within nursing and how some workplace environments can hinder, not promote, ...

An AI model designed to automate assessment of delirium risk increased the number of detected cases among hospitalized older ...

As Consumers Search for the Best Non-Prescription Eye Supplements in 2025, Visium Pro Highlights Clean Label Formulation, GMP ...

Readers broadly welcomed the ambition of Labour’s 10-year NHS plan but questioned whether, without proper funding, staffing ...

Covid has caused serious amounts of chronic illness. Research advances may help not only people facing chronic illnesses ...

One of the habits that classy people stick to on a regular basis is keeping their cool and remaining even keeled when ...

Which skincare ingredients actually work? A new study reveals the 23 ingredients leading dermatologists trust most — backed by expert consensus and strong clinical evidence.k ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

PURPOSEGEMPAX was an open-label, randomized phase III clinical trial designed to assess the efficacy and tolerability of gemcitabine plus paclitaxel versus gemcitabine alone as second-line treatment ...